| pubmed-article:123680 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:123680 | lifeskim:mentions | umls-concept:C0004651 | lld:lifeskim |
| pubmed-article:123680 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:123680 | lifeskim:mentions | umls-concept:C0008972 | lld:lifeskim |
| pubmed-article:123680 | lifeskim:mentions | umls-concept:C0038170 | lld:lifeskim |
| pubmed-article:123680 | lifeskim:mentions | umls-concept:C0080103 | lld:lifeskim |
| pubmed-article:123680 | lifeskim:mentions | umls-concept:C0038167 | lld:lifeskim |
| pubmed-article:123680 | lifeskim:mentions | umls-concept:C0450442 | lld:lifeskim |
| pubmed-article:123680 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:123680 | pubmed:dateCreated | 1975-7-1 | lld:pubmed |
| pubmed-article:123680 | pubmed:abstractText | In comparing the bacteriophage group reference of the strains of pathogenic staphylococci isolated in case of postoperative complications from children given staphylococcus toxoid for prophylactic purpose and from control group it was found that prophylactic vaccinations of staphylococcus toxoid created the most intense immunity against staphylococci of the I bacteriophage group. There was found no significant association between the efficacy of the therapy and bacteriophage reference of staphylococci--the causative agents of the infection. | lld:pubmed |
| pubmed-article:123680 | pubmed:language | rus | lld:pubmed |
| pubmed-article:123680 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:123680 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:123680 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:123680 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:123680 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:123680 | pubmed:issn | 0372-9311 | lld:pubmed |
| pubmed-article:123680 | pubmed:author | pubmed-author:AkatovA KAK | lld:pubmed |
| pubmed-article:123680 | pubmed:author | pubmed-author:SnopkovaV AVA | lld:pubmed |
| pubmed-article:123680 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:123680 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:123680 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:123680 | pubmed:pagination | 73-5 | lld:pubmed |
| pubmed-article:123680 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:123680 | pubmed:meshHeading | pubmed-meshheading:123680-H... | lld:pubmed |
| pubmed-article:123680 | pubmed:meshHeading | pubmed-meshheading:123680-C... | lld:pubmed |
| pubmed-article:123680 | pubmed:meshHeading | pubmed-meshheading:123680-S... | lld:pubmed |
| pubmed-article:123680 | pubmed:meshHeading | pubmed-meshheading:123680-S... | lld:pubmed |
| pubmed-article:123680 | pubmed:meshHeading | pubmed-meshheading:123680-S... | lld:pubmed |
| pubmed-article:123680 | pubmed:meshHeading | pubmed-meshheading:123680-I... | lld:pubmed |
| pubmed-article:123680 | pubmed:meshHeading | pubmed-meshheading:123680-S... | lld:pubmed |
| pubmed-article:123680 | pubmed:meshHeading | pubmed-meshheading:123680-B... | lld:pubmed |
| pubmed-article:123680 | pubmed:meshHeading | pubmed-meshheading:123680-S... | lld:pubmed |
| pubmed-article:123680 | pubmed:year | 1975 | lld:pubmed |
| pubmed-article:123680 | pubmed:articleTitle | [Clinical study of the efficacy of staphylococcal anatoxin in relation to the phage group to which the staphylococcal strains--the causative agents of infection--belong]. | lld:pubmed |
| pubmed-article:123680 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:123680 | pubmed:publicationType | English Abstract | lld:pubmed |
